Lyka Labs Gets CDSCO Panel Nod To Manufacture, Market Atopic Dermatitis Drug Dr. Divya Colin2 Oct 2023 5:30 PM ISTNew Delhi: Lyka Lab has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO)...
Submit BE study, Phase III trial protocol: CDSCO panel tells Glenmark on Metformin, Glimepiride, Lobeglitazon FDC Susmita Roy1 Oct 2023 6:00 PM ISTNew Delhi: Citing the proposed fixed-dose combination (FDC) is not approved internationally, the Subject Expert Committee (SEC) functional under the...
CDSCO panel tells Glenmark to provide in-vivo data, global data concerning Pulmonary FDC in inhalation suspension Roshni Dhar1 Oct 2023 3:15 PM ISTIn reaction to the request for a waiver of bioequivalence (BE) and Phase III clinical trials for the inhalation suspension of the pulmonary drug...
Sun Pharma Gets CDSCO Panel Nod To Market Sitagliptin, Metformin, Glimepiride FDC in Lower Strength Dr. Divya Colin30 Sept 2023 6:00 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Health Bulletin 30/September/2023 Roshni Dhar30 Sept 2023 4:22 PM ISTHere are the top health stories for the day:Names of medical colleges not paying stipend to medicos should be made publicStating that the names of the...
Zydus gets CDSCO permission to begin PCSK9 inhibitor Phase I clinical study Ruchika Sharma30 Sept 2023 12:30 PM ISTAhmedabad: Zydus, a discovery-based, global pharmaceutical company, has announced that it has received permission from CDSCO, India to initiate the...
Revise phase III trial protocol: CDSCO Panel tells Bharath Biotech on Inactivated Japanese Encephalitis vaccine Dr. Divya Colin29 Sept 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by vaccine maker Bharath Biotech for a grant of permission to conduct a Phase III clinical trial for...
Provide in-vivo data, global data: CDSCO Panel Tells Glenmark on Pulmonary FDC in Inhalation Suspension Dr. Divya Colin28 Sept 2023 6:00 PM ISTNew Delhi: In reaction to the request for a waiver of bioequivalence (BE) and Phase III clinical trials for the inhalation suspension of the pulmonary...
Drug Alert: CDSCO flags 48 medicine batches for failing to qualify for random drug sample test Isra Zaman28 Sept 2023 3:30 PM ISTIn its latest drug alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 48 medicine batches for...
Sanofi gets CDSCO panel nod to study atopic dermatitis drug Amlitelimab Dr. Divya Colin27 Sept 2023 6:00 PM ISTNew Delhi: The drug major Sanofi has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Health Bulletin 27/September/2023 Isra Zaman27 Sept 2023 5:00 PM ISTHere are the top health stories for the day:NEET PG 2023: SC refuses to entertain plea challenging 'Zero' cutoff percentileObserving that the...
CDSCO Drug Alert: 48 Drug Samples Flagged Susmita Roy26 Sept 2023 6:00 PM ISTNew Delhi: In its latest drug alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 48 medicine...
